| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Alnylam Pharmaceuticals (ALNY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The overall sentiment for Alnylam Pharmaceuticals is positive (overall 1.4, positive 3.2, negative -1.8) on 2025-10-20. The forces of Sentiment towards Fundamentals (2.3), Stock Price Trend (2), Option Sentiment (1.5), and Sector Price Trend (1) will drive up the price. The forces of Price Level Sentiment (-1), Market Risk Appetite (-1.1), and Valuation Sentiment (-1.5) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (3.2). The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Market Sentiment | Action | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-20 | 0% | 0% | 491.22 | 114 | 1.98% | 0.84% | 2 | 0.5 | Short | 2.3 | -1.5 |
| 2025-10-19 | 0% | 0% | 1.8 | 0.3 | Short | 2.5 | -1.5 | ||||
| 2025-10-18 | 0% | 0% | 1.8 | 0.3 | Short | 2.5 | -1.5 | ||||
| 2025-10-17 | 0% | 0% | 481.67 | 108 | 0.12% | 0.56% | 1.8 | 0.4 | Short | 2.5 | -1.5 |
| 2025-10-16 | 0% | 0% | 481.07 | 120 | 2.3% | 0.43% | 1.2 | 0.3 | Short | 2.9 | -1.5 |
| 2025-10-15 | 0% | 0% | 470.27 | 103 | 0.19% | 0.2% | 1 | 0.1 | Short | 2.4 | -1.5 |
| 2025-10-14 | 0% | 0% | 469.36 | 109 | 0.95% | 0.31% | 0.5 | 0.1 | Short | 2.2 | -1.5 |
| 2025-10-13 | 0% | 0% | 464.95 | 97 | 1.04% | 0.37% | 0.6 | 0.2 | Short | 2.1 | -1.5 |
| 2025-10-12 | 0% | 0% | 0.4 | 0.4 | Range | 2.1 | -1.5 | ||||
| 2025-10-11 | 0% | 0% | 0.4 | 0.6 | Range | 3.2 | -1.5 | ||||
| Trend sentiment reflects the price change, and market sentiment scores are calculated from many factors. Sentiment towards fundamentals and news sentiment are extracted from news headline. All sentiment scores are normalized in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. | Range refers to range trade strategy. In an uptrend, the price will likely bullback after huge advance. As an investor, you may want to wait for the pullback to open long position. As a trader, you may consider tactical short. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. As a trader, you may consider tactical long. |
| 2025-10-20 17:08:15 Current trends in the pharmaceutical market indicate that companies like Alnylam could benefit from favorable conditions. |
| 2025-10-20 17:08:15 The potential for Alnylam's stock to surge indicates favorable conditions for investors looking at biotech opportunities. |
| 2025-10-20 17:08:15 Analysts have expressed optimism regarding Alnylam's potential for growth, contributing to positive market sentiment. |
| 2025-10-20 17:08:15 Positive earnings estimate revisions suggest that Alnylam is expected to perform well in the upcoming earnings reports. |
| 2025-10-20 17:08:15 Alnylam Pharmaceuticals' stock has shown positive movement, closing higher and indicating potential for continued growth. |